Published on: May 2022
The Cell Culture Boom
The global cell culture market is expected to grow at a CAGR of 12.6 percent between 2021 and 2026, from USD 22.8 billion in 2021 to USD 41.3 billion in 2026. Growing awareness of the benefits of cell-based vaccines, rising demand for monoclonal antibodies (mAbs), funding for cell-based research, rising preference for single-use technologies, the introduction of advanced cell culture products, and a growing focus on personalised medicine are all driving this market forward. The high expense of cell biology research, on the other hand, is limiting the market's expansion. Impact of COVID-19 on the Cell Culture Market
The Pandemic Effect
COVID-19 is a newly identified novel coronavirus that causes infectious sickness. COVID-19, which was mostly unknown before the outbreak in Wuhan, China, in December 2019, has evolved from a regional issue to a global pandemic. The COVID-19 pandemic has put a strain on healthcare systems all around the world. According to the World Health Organisation, there were 271,963,258 confirmed COVID-19 cases, with 5,331,019 deaths (as of December 17, 2021). The Americas had the highest number of deaths, followed by Europe and Southeast Asia.
The COVID-19 pandemic has motivated major pharmaceutical and biotechnology companies to develop a number of COVID-19 vaccines or antiviral medications that have been approved or are in the development stage.
Whether it is pandemic or an epidemic, what really helps you and your brand is a brilliant insight to begin with. Authentic insights can help you knock on the door of success. Get your expert report from the expert corner at Marketing Insight! <hyperlink>